Stifel Nicolaus Has Lowered Expectations for Quipt Home Medical (TSE:QIPT) Stock Price

Quipt Home Medical (TSE:QIPTFree Report) had its target price decreased by Stifel Nicolaus from C$8.40 to C$7.50 in a report released on Thursday morning,BayStreet.CA reports. Stifel Nicolaus currently has a buy rating on the stock.

Quipt Home Medical Trading Up 3.8 %

Shares of TSE:QIPT opened at C$3.56 on Thursday. Quipt Home Medical has a 12-month low of C$3.28 and a 12-month high of C$6.98. The company has a market cap of C$153.40 million, a PE ratio of -20.88 and a beta of 1.01. The stock has a 50 day moving average of C$3.72 and a 200 day moving average of C$4.14.

About Quipt Home Medical

(Get Free Report)

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.

See Also

Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.